Enhancing activity and overcoming chemoresistance in hematologic malignancies with bortezomib: preclinical mechanistic studies.

Reddy, N

Enhancing activity and overcoming chemoresistance in hematologic malignancies with bortezomib: preclinical mechanistic studies. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Sep 2010 - 1756-1764 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1569-8041

10.1093/annonc/mdq009 doi


Animals
Antineoplastic Agents--therapeutic use
Boronic Acids--therapeutic use
Bortezomib
Clinical Trials as Topic
Drug Evaluation, Preclinical
Drug Resistance, Neoplasm--drug effects
Hematologic Neoplasms--drug therapy
Humans
Pyrazines--therapeutic use